Company / SG&A per Share
Amgen SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$13.13
FY2025
5-year range
$9.28 / $13.25
FY2021-FY2025
Trend
-0.9%
vs FY2024
Sector context
#10 of 208
Health Care
What the data says
Among 208 Health Care companies, Amgen is in the bottom 5% for sg&a per share. SG&A per Share has fluctuated over the past 10 years, ranging from $6.60 in FY2017 to $13.25 in FY2024.
Based on SEC 10-K filings.
13.13 in FY2025 with a 5-year CAGR of +6.3%. Top quartile in the Health Care sector.
Increased from $11.57 to $13.13 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +10.6%
- 5-Year CAGR
- +6.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 208This company $13.13 Sector average $29.78
▼
-55.9% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share decreased 0.9% year-over-year.
- Ranks #10 out of 208 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2024.
- Lowest sg&a per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.55 (distress zone, below 1.8 threshold)
- Strong return on equity: 72.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $13.13 | -0.9% |
| FY2024 | $13.25 | +14.5% |
| FY2023 | $11.57 | +19.3% |
| FY2022 | $9.70 | +4.5% |
| FY2021 | $9.28 | -4.2% |
| FY2020 | $9.69 | +18.4% |
| FY2019 | $8.18 | +10.8% |
| FY2018 | $7.38 | +11.9% |
| FY2017 | $6.60 | -1.7% |
| FY2016 | $6.71 | +5.3% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026